Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Leukemia
|
May 21, 2010
Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma
L F Porrata, K Rsitow, D J Inwards, et al.
Eye (London, England)
|
June 22, 2013
Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation
J S Pulido, T J Flotte, H Raja, et al.
Leukemia
|
May 25, 2011
The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma
R A Wilcox, K Ristow, T M Habermann, et al.
Bone Marrow Transplantation
|
December 17, 2003
Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma
L F Porrata, M R Litzow, D J Inwards, et al.
Blood Cancer Journal
|
April 20, 2013
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma
L F Porrata, K M Ristow, T M Habermann, et al.
Leukemia
|
March 26, 2004
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma
L F Porrata, M A Gertz, S M Geyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2013
Bowel perforation in intestinal lymphoma: incidence and clinical features
R Vaidya, T M Habermann, J H Donohue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial
J Guo, R D Carvajal, R Dummer, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
February 17, 2009
Metastatic malignant melanoma
S N Markovic, L A Erickson, T J Flotte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 6, 2023
Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia
S H Cass, J W D Tobin, Y D Seo, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Leukemia
|
May 21, 2010
Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma
L F Porrata, K Rsitow, D J Inwards, et al.
Eye (London, England)
|
June 22, 2013
Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation
J S Pulido, T J Flotte, H Raja, et al.
Leukemia
|
May 25, 2011
The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma
R A Wilcox, K Ristow, T M Habermann, et al.
Bone Marrow Transplantation
|
December 17, 2003
Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma
L F Porrata, M R Litzow, D J Inwards, et al.
Blood Cancer Journal
|
April 20, 2013
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma
L F Porrata, K M Ristow, T M Habermann, et al.
Leukemia
|
March 26, 2004
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma
L F Porrata, M A Gertz, S M Geyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2013
Bowel perforation in intestinal lymphoma: incidence and clinical features
R Vaidya, T M Habermann, J H Donohue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial
J Guo, R D Carvajal, R Dummer, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
February 17, 2009
Metastatic malignant melanoma
S N Markovic, L A Erickson, T J Flotte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 6, 2023
Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia
S H Cass, J W D Tobin, Y D Seo, et al.
Page
of 4